Whole-exome sequencing reveals the impact of UVA light mutagenesis in xeroderma pigmentosum variant human cells Moreno and Souza et al. Supplementary data Supplementary Figure 1. Experimental strategy to detect point mutations using whole-exome sequencing (WES). XP-V complemented (XP-V comp), and XP-V cells (XP-V) were irradiated with 120 kJ/m 2 of UVA light and then subjected to a 45-day cloning procedure based on colony selection and expansion. Genomic DNA was extracted from four clones of each cell type and treatment. Whole-exome enrichment was performed to construct libraries for sequencing on HiSeq Platform. Read mapping and SNP calling were done using BWA-GATK pipeline.
Supplementary Figure 4 . Somatic spectrum of mutations in each cell clone sequenced. Somatic spectrum of point mutations and its trinucleotide context sequence extracted in each cell line clone. Clones colored in red, orange, light green and blue corresponds to XP-V comp, XP-V comp UVA, XP-V, and XP-V UVA, respectively. Trinucleotide contribution was calculated by its frequency. 
Supplementary

Supplementary Methods
Color-space reads produced by SOLiD were mapped to the GRCh37/hg19 genome using the LifeScope v2.1 software package (Life Technologies, Carlsbad, California, EUA). SNP calling was performed by using the DiBayes algorithm to detect two adjacent SNPs. SNPs were called only if the altered allele supporting reads were higher than 0.15 and covered at least 2X.
To identify induced point mutations and filter out polymorphisms, unique single nucleotide variants (SNVs) were selected, considering the position and nucleotide change in comparison to all other samples sequenced, despite genotyping assignment. Whenever a variant was detected in two or more independent clones, it was considered a polymorphism and was discarded. Comparisons were performed using VCFtools, and unique SNVs for each sample were annotated with ANNOVAR using RefSeq. Alternatively, an additional filtering step involving only SNVs annotated as "exonic" or "splicing" in each clone sample was applied to restrict the analysis only to regions enriched in exome sequencing.
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